Stocktoria

Ping An Biomedical Co., Ltd. PASW

Ping An Biomedical Co., Ltd. statistics & valuation

Profitability & efficiency

Net margin (%)
-1.50% -37.60% 20242025
Gross margin (%)
6.20% 2.80% 20242025
Operating margin (%)
0.00% -43.10% 20242025
Return on equity (%)
-28.40% 20242025
Shares outstanding
18.0M 20.5M 20242025
Net debt ($)
20242025
Share buybacks ($)
20242025
Return on assets (%)
-2.30% -18.80% 20242025
Free cash flow margin (%)
20242025
Debt / equity (×)
20242025
EPS ($)
-$0.07 -$0.10 20242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024
Gross margin2.8%6.2%
Operating margin-43.1%-0.0%
Net margin-37.6%-1.5%
Return on assets-18.8%-2.3%
Return on equity-28.4%17.9%
Current ratio2.760.84

Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.